LOINC Code 100345-8: Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel NAA+probe (Specimen)
100345-8 is a LOINC code used to identify Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel NAA+probe (Specimen) in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Influenza virus A & Influenza virus B & SARS coronavirus 2 RNA panel. It is commonly used with the system or sample type XXX.
What is this code?
LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Influenza virus A & Influenza virus B & SARS coronavirus 2 RNA panel. It is commonly used with the system or sample type XXX.
When is it used?
- Used in lab systems, EHRs, and clinical data exchange.
- May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
- Status: ACTIVE
- Order vs observation: Both
- Panel type: Panel
- Method: Probe.amp.tar
What it does not mean
- The code identifies the observation or test, not the actual result.
Key facts
- Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection
- Influenza virus A & Influenza virus B & SARS coronavirus 2 RNA panel
- This is a real-time RT-PCR panel for qualitative detection and differentiation of Influenza A virus RNA, Influenza B virus RNA, and SARS-CoV-2 RNA in multiple specimen types (upper respiratory, lower respiratory, or saliva). The assays in this panel could contain primers and probes for one gene target or multiple gene targets for each analyte.
- 2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUABV + SARS-CoV-2; FLUABV+SARS-CoV-2 RNA Pnl; FLUAV; FLUB; FLUBV; FLUV; Fowl plague; ID; II; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Influenza B; Influenza B virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; PH; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Public Health; PublicHealth; QBR; Random; Ribonucleic acid; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 RNA Pnl; SDA; Severe Acute Respiratory Syndrome; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Viral Pneumonias; Wuhan coronavirus
Where you may see this code
You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.
Common synonyms
Frequently asked questions
About this content
This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.